E
0.032
0.00 (-5.88%)
| Previous Close | 0.034 |
| Open | 0.033 |
| Volume | 137,828 |
| Avg. Volume (3M) | 348,288 |
| Market Cap | 13,905,633 |
| Price / Sales | 5.87 |
| Price / Book | 6.07 |
| 52 Weeks Range | |
| Earnings Date | 22 Aug 2024 - 23 Aug 2024 |
| Operating Margin (TTM) | -10.55% |
| Diluted EPS (TTM) | -0.030 |
| Quarterly Revenue Growth (YOY) | 29.40% |
| Total Debt/Equity (MRQ) | 70.86% |
| Current Ratio (MRQ) | 0.860 |
| Operating Cash Flow (TTM) | -4.28 M |
| Levered Free Cash Flow (TTM) | -3.48 M |
| Return on Assets (TTM) | -26.71% |
| Return on Equity (TTM) | -248.53% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (AU) | Mixed | Mixed |
| Health Information Services (Global) | Mixed | Bearish | |
| Stock | EMYRIAL FPO [EMD] | - | - |
AIStockmoo Score
0.0
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | 0.00 |
|
Emyria Ltd operates a network of specialist medical clinics and uses purpose-built software and technology to gather clinical data from consenting patients. It operates in one segment of research and development. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Value |
| % Held by Insiders | 27.24% |
| % Held by Institutions | 5.24% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |